BPIFA2 | BPI fold containing family A, member 2 | Predicted secreted proteins
| | | | | Tissue enriched |
CA6 | Carbonic anhydrase VI | Enzymes Predicted secreted proteins
| | | | | Tissue enriched |
C4orf40 | Chromosome 4 open reading frame 40 | Predicted secreted proteins
| | | | | Tissue enriched |
SMR3A | Submaxillary gland androgen regulated protein 3A | Predicted secreted proteins
| | | | | Tissue enriched |
MUC7 | Mucin 7, secreted | Disease related genes Predicted secreted proteins
| | | | | Tissue enriched |
PIP | Prolactin-induced protein | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
STATH | Statherin | Plasma proteins Predicted secreted proteins Transporters
| | | | | Tissue enriched |
CST5 | Cystatin D | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
LPO | Lactoperoxidase | Enzymes Predicted secreted proteins
| | | | | Tissue enriched |
PRR4 | Proline rich 4 (lacrimal) | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
CST2 | Cystatin SA | Predicted secreted proteins
| | | | | Tissue enriched |
ZG16B | Zymogen granule protein 16B | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
AMY1A | Amylase, alpha 1A (salivary) | Enzymes Predicted secreted proteins
| | | | | Group enriched |
SLC5A5 | Solute carrier family 5 (sodium/iodide cotransporter), member 5 | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
AMY1C | Amylase, alpha 1C (salivary) | Enzymes Predicted secreted proteins
| | | | | Group enriched |
AMY1B | Amylase, alpha 1B (salivary) | Enzymes Predicted secreted proteins
| | | | | Group enriched |
CST4 | Cystatin S | Predicted secreted proteins
| | | | | Tissue enriched |
BPIFB2 | BPI fold containing family B, member 2 | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
BSND | Bartter syndrome, infantile, with sensorineural deafness (Barttin) | Disease related genes Predicted membrane proteins
| | | | | Group enriched |
CALML5 | Calmodulin-like 5 | Plasma proteins RAS pathway related proteins
| | | | | Group enriched |
CST1 | Cystatin SN | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
BHLHA15 | Basic helix-loop-helix family, member a15 | Transcription factors
| | | | | Group enriched |
MUCL1 | Mucin-like 1 | Predicted secreted proteins
| | | | | Tissue enriched |
AGFG2 | ArfGAP with FG repeats 2 | | | | | | Tissue enriched |
ATP6V0A4 | ATPase, H+ transporting, lysosomal V0 subunit a4 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
DMBT1 | Deleted in malignant brain tumors 1 | Disease related genes Predicted secreted proteins
| | | | | Group enriched |
SIX1 | SIX homeobox 1 | Disease related genes Transcription factors
| | | | | Group enriched |
SLC13A2 | Solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 2 | Predicted membrane proteins Transporters
| | | | | Group enriched |
ZNF750 | Zinc finger protein 750 | Cancer-related genes Disease related genes
| | | | | Group enriched |
BPIFA1 | BPI fold containing family A, member 1 | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
CFTR | Cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
PITX1 | Paired-like homeodomain 1 | Disease related genes Transcription factors
| | | | | Group enriched |
S100A1 | S100 calcium binding protein A1 | Cancer-related genes Plasma proteins
| | | | | Group enriched |
PIGR | Polymeric immunoglobulin receptor | Cancer-related genes Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
SHC3 | SHC (Src homology 2 domain containing) transforming protein 3 | Plasma proteins RAS pathway related proteins
| | | | | Group enriched |
ANO1 | Anoctamin 1, calcium activated chloride channel | FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
AQP5 | Aquaporin 5 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ATP2B2 | ATPase, Ca++ transporting, plasma membrane 2 | Enzymes Plasma proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ATP6V1B1 | ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1 | Disease related genes
| | | | | Tissue enhanced |
AZGP1 | Alpha-2-glycoprotein 1, zinc-binding | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
BARX2 | BARX homeobox 2 | Transcription factors
| | | | | Tissue enhanced |
BPIFB1 | BPI fold containing family B, member 1 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CLDN10 | Claudin 10 | Predicted membrane proteins
| | | | | Tissue enhanced |
CRISP3 | Cysteine-rich secretory protein 3 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
EFCAB4B | EF-hand calcium binding domain 4B | | | | | | Tissue enhanced |
FDCSP | Follicular dendritic cell secreted protein | Predicted secreted proteins
| | | | | Tissue enhanced |
HSD11B2 | Hydroxysteroid (11-beta) dehydrogenase 2 | Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
KLK15 | Kallikrein-related peptidase 15 | Cancer-related genes Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
LRRTM1 | Leucine rich repeat transmembrane neuronal 1 | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
LTF | Lactotransferrin | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |